Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page
- CheckyesterdayChange DetectedThe page now states that recruitment is no longer ongoing, clarifying the trial's enrollment status. It also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with a revision tag to v3.6.0.SummaryDifference0.5%

- Check8 days agoChange DetectedThe page now shows a new Revision: v3.5.5, replacing v3.5.4, indicating a small site update without changes to the study details.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a new version of the page. This update reflects a metadata/version control change rather than substantive content changes.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s footer software/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” with no associated changes to the underlying study information.SummaryDifference0.1%

- Check57 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check87 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No visible changes to the study details page or layout.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.